rs137852618
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PS1_ModeratePM1PM2PP3_StrongPP5_Very_Strong
The NM_000211.5(ITGB2):c.817G>A(p.Gly273Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000626 in 1,613,960 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely pathogenicin UniProt. Synonymous variant affecting the same amino acid position (i.e. G273G) has been classified as Benign.
Frequency
Consequence
NM_000211.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ITGB2 | NM_000211.5 | c.817G>A | p.Gly273Arg | missense_variant | 7/16 | ENST00000652462.1 | NP_000202.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITGB2 | ENST00000652462.1 | c.817G>A | p.Gly273Arg | missense_variant | 7/16 | NM_000211.5 | ENSP00000498780 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152192Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251282Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135866
GnomAD4 exome AF: 0.0000629 AC: 92AN: 1461768Hom.: 0 Cov.: 33 AF XY: 0.0000440 AC XY: 32AN XY: 727174
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152192Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74338
ClinVar
Submissions by phenotype
Leukocyte adhesion deficiency 1 Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 20, 2023 | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Experimental studies have shown that this missense change affects ITGB2 function (PMID: 9884339). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ITGB2 protein function. ClinVar contains an entry for this variant (Variation ID: 9471). This missense change has been observed in individual(s) with leukocyte adhesion deficiency type 1 (PMID: 9884339, 30919141; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs137852618, gnomAD 0.003%). This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 273 of the ITGB2 protein (p.Gly273Arg). - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 01, 1999 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Mar 30, 2021 | ITGB2 NM_000211.4 exon 7 p.Gly273Arg (c.817G>A): This variant has been reported in the literature in at least 3 individuals with Leukocyte Adhesion Deficiency Type-I (LAD-I) as homozygous or compound heterozygotes (Hogg 1999 PMID:9664339, Yamazaki-Nakashima 2015 PMID:25527966). This variant is present in 3/126630 European alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/rs137852618). This variant is present in ClinVar (Variation ID:9471). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In addition, functional studies suggest a deleterious effect of this variant, potentially impacting the cell surface expression of Beta-2 integrins (Hogg 1999 PMID:9664339, Guan 2015 PMID:25514840, Yamazaki-Nakashima 2015 PMID:25527966). In summary, data on this variant is highly suspicious for disease, but requires further evidence for pathogenicity. Therefore, this variant classified as likely pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 22, 2023 | Published functional studies demonstrate a damaging effect through a lack of expression of LFA-1 on the surface of cells expressing this variant (Hogg et al., 1999; Yamazaki-Nakashimada et al., 2015); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; In silico analysis suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 17651379, 30312521, 30968598, 34310689, 10936446, 25527966, 22134107, 25514840, 25703682, 30919141, 9884339, 31965297, 32279896, 33391282, 33365035, 33240318) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at